Go Pro
→ Trump’s $250 Bill – See Immediately (From Stansberry Research) (Ad)tc pixel Free NXL Stock Alerts

Nexalin Technology (NXL) Financials

Nexalin Technology logo
$0.49 +0.01 (+2.83%)
As of 10:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Nexalin Technology

Annual Income Statements for Nexalin Technology

This table shows Nexalin Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -6.08 -1.70 -4.65 -7.61 -8.22
Consolidated Net Income / (Loss)		 -6.08 -1.70 -4.65 -7.61 -8.22
Net Income / (Loss) Continuing Operations		 -6.10 -1.68 -4.65 -7.61 -8.22
Total Pre-Tax Income 		-6.10 -1.68 -4.65 -7.61 -8.22
Total Operating Income		 -6.02 -1.83 -5.70 -7.75 -8.39
Total Gross Profit		 0.12 0.96 0.09 0.13 0.24
Total Revenue		 0.14 1.32 0.11 0.17 0.30
Operating Revenue		 0.14 1.32 0.11 0.17 0.30
Total Cost of Revenue		 0.02 1.06 0.03 0.04 0.06
Operating Cost of Revenue		 0.02 1.06 0.03 0.04 0.06
Total Operating Expenses		 6.14 2.10 5.78 7.89 8.63
Selling, General & Admin Expense		 6.14 2.10 3.86 6.70 7.55
Research & Development Expense		 - - 1.92 1.19 1.08
Total Other Income / (Expense), net		 -0.08 0.14 1.05 0.14 0.17
Interest Expense		 0.08 0.06 -0.58 -0.00 -0.01
Interest & Investment Income		 - 0.00 0.23 0.13 0.13
Other Income / (Expense), net		 0.00 0.21 0.24 0.01 0.03
Income Tax Expense		 - - 0.00 0.00 0.00
Basic Earnings per Share		 ($1.43) ($0.30) ($0.63) ($0.83) ($0.50)
Weighted Average Basic Shares Outstanding		 4.26M 5.57M 7.36M 9.22M 16.39M
Diluted Earnings per Share		 ($1.43) ($0.30) ($0.63) ($0.83) ($0.50)
Weighted Average Diluted Shares Outstanding		 4.26M 5.57M 7.36M 9.22M 16.39M
Weighted Average Basic & Diluted Shares Outstanding		 4.26M 5.57M 7.44M 13.30M 20.58M

Quarterly Income Statements for Nexalin Technology

This table shows Nexalin Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -2.30 -0.78 -1.04 -1.28 -2.45 -2.83 -1.99 -1.58 -2.28 -2.38 -2.10
Consolidated Net Income / (Loss)		 -2.30 -0.78 -1.04 -1.28 -2.45 -2.83 -1.99 -1.58 -2.28 -2.38 -2.10
Net Income / (Loss) Continuing Operations		 -2.30 -0.78 -1.05 -1.28 -2.45 -2.83 -1.99 -1.58 -2.28 -2.38 -2.10
Total Pre-Tax Income 		-2.30 -0.78 -1.05 -1.28 -2.45 -2.83 -1.99 -1.58 -2.28 -2.38 -2.10
Total Operating Income		 -2.42 -1.62 -1.07 -1.30 -2.51 -2.88 -2.01 -1.62 -2.35 -2.41 -2.12
Total Gross Profit		 0.02 0.02 0.07 0.02 0.02 0.02 0.03 0.05 0.01 0.15 0.01
Total Revenue		 0.02 0.02 0.08 0.03 0.04 0.03 0.04 0.07 0.02 0.17 0.01
Operating Revenue		 0.02 0.02 0.08 0.03 0.04 0.03 0.04 0.07 0.02 0.17 0.01
Total Cost of Revenue		 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.00 0.02 0.00
Operating Cost of Revenue		 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.00 0.02 0.00
Total Operating Expenses		 2.44 1.64 1.14 1.32 2.53 2.90 2.04 1.67 2.36 2.56 2.13
Selling, General & Admin Expense		 2.44 -0.28 1.04 1.15 2.35 2.16 1.63 1.44 2.13 2.34 1.79
Research & Development Expense		 - - 0.11 0.17 0.18 0.74 0.41 0.23 0.23 0.22 0.35
Total Other Income / (Expense), net		 0.12 0.84 0.03 0.01 0.06 0.04 0.02 0.04 0.07 0.04 0.02
Interest Expense		 0.01 -0.60 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Interest & Investment Income		 0.08 0.05 0.02 0.01 0.06 0.04 0.02 0.03 0.05 0.03 0.02
Other Income / (Expense), net		 0.04 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 0.00
Income Tax Expense		 - - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Basic Earnings per Share		 ($0.31) ($0.11) ($0.14) ($0.17) ($0.23) ($0.29) ($0.15) ($0.10) ($0.13) ($0.12) ($0.11)
Weighted Average Basic Shares Outstanding		 7.42M 7.36M 7.44M 7.50M 10.85M 9.22M 13.31M 15.72M 17.79M 16.39M 19.82M
Diluted Earnings per Share		 ($0.31) ($0.11) ($0.14) ($0.17) ($0.23) ($0.29) ($0.15) ($0.10) ($0.13) ($0.12) ($0.11)
Weighted Average Diluted Shares Outstanding		 7.42M 7.36M 7.44M 7.50M 10.85M 9.22M 13.31M 15.72M 17.79M 16.39M 19.82M
Weighted Average Basic & Diluted Shares Outstanding		 7.44M 7.44M 7.44M 10.59M 12.86M 13.30M 17.18M 17.42M 18.65M 20.58M 20.58M

Annual Cash Flow Statements for Nexalin Technology

This table details how cash moves in and out of Nexalin Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.58 -0.50 0.42 -0.01 0.08
Net Cash From Operating Activities		 -1.08 -2.22 -3.84 -3.94 -4.96
Net Cash From Continuing Operating Activities		 -1.08 -2.22 -3.84 -3.94 -4.96
Net Income / (Loss) Continuing Operations		 -6.08 -1.70 -4.65 -7.61 -8.22
Consolidated Net Income / (Loss)		 -6.08 -1.70 -4.65 -7.61 -8.22
Amortization Expense		 - 0.00 0.00 0.02 0.02
Non-Cash Adjustments To Reconcile Net Income		 4.48 0.12 1.27 3.53 3.01
Changes in Operating Assets and Liabilities, net		 0.52 -0.63 -0.46 0.12 0.23
Net Cash From Investing Activities		 0.00 -6.79 4.45 -0.58 -0.13
Net Cash From Continuing Investing Activities		 0.00 -6.79 4.45 -0.58 -0.13
Acquisitions		 - 0.00 -0.19 -0.12 -0.06
Purchase of Investments		 0.00 -6.79 -37 -34 -41
Sale and/or Maturity of Investments		 - 0.00 41 33 41
Other Investing Activities, net		 - 0.00 -0.01 -0.05 -0.04
Net Cash From Financing Activities		 1.66 8.51 -0.20 4.52 5.17
Net Cash From Continuing Financing Activities		 1.67 8.51 -0.20 4.52 5.17
Issuance of Common Equity		 1.43 8.55 0.00 4.52 4.65
Other Financing Activities, net		 0.04 -0.03 -0.20 0.00 0.52

Quarterly Cash Flow Statements for Nexalin Technology

This table details how cash moves in and out of Nexalin Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.13 0.22 -0.03 0.30 -0.77 0.49 0.05 -0.19 0.16 0.06 0.55
Net Cash From Operating Activities		 -0.70 -1.00 -0.76 -1.25 -0.80 -1.13 -1.43 -0.92 -1.47 -1.15 -1.71
Net Cash From Continuing Operating Activities		 -0.70 -1.00 -0.76 -1.25 -0.80 -1.13 -1.43 -0.91 -1.48 -1.15 -1.71
Net Income / (Loss) Continuing Operations		 -2.30 -0.78 -1.04 -1.28 -2.45 -2.83 -1.99 -1.58 -2.28 -2.38 -2.10
Consolidated Net Income / (Loss)		 -2.30 -0.78 -1.04 -1.28 -2.45 -2.83 -1.99 -1.58 -2.28 -2.38 -2.10
Depreciation Expense		 0.00 0.00 - - - - 0.00 - - - 0.00
Amortization Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Non-Cash Adjustments To Reconcile Net Income		 1.49 -0.22 0.13 0.30 1.48 1.61 0.62 0.54 1.00 0.85 0.46
Changes in Operating Assets and Liabilities, net		 0.10 -0.01 0.15 -0.27 0.16 0.08 -0.06 0.13 -0.21 0.37 -0.08
Net Cash From Investing Activities		 0.83 1.22 0.73 1.55 -4.48 1.63 1.47 -3.92 1.63 0.69 1.51
Net Cash From Continuing Investing Activities		 0.83 1.22 0.73 1.55 -4.48 1.63 1.47 -3.92 1.63 0.69 1.51
Purchase of Property, Plant & Equipment		 - - - - - - 0.00 - - - -0.05
Acquisitions		 -0.03 -0.10 -0.05 -0.03 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01
Purchase of Investments		 -11 -7.35 -5.44 -1.32 -18 -9.23 -5.00 -15 -12 -8.76 -4.00
Sale and/or Maturity of Investments		 12 8.61 6.24 2.93 13 11 6.50 11 14 9.48 5.59
Other Investing Activities, net		 -0.07 0.06 -0.02 -0.03 -0.01 -0.00 -0.00 -0.01 -0.01 -0.02 -0.02
Net Cash From Financing Activities		 - - 0.00 - 4.52 - 0.00 4.65 - 0.52 0.76
Net Cash From Continuing Financing Activities		 - - 0.00 - 4.52 - 0.00 4.65 - 0.52 0.76
Other Financing Activities, net		 - - - - - - 0.00 - - - 0.76

Annual Balance Sheets for Nexalin Technology

This table presents Nexalin Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 0.75 7.43 3.63 4.22 4.64
Total Current Assets		 0.75 7.43 3.43 3.96 4.30
Cash & Equivalents		 0.66 0.16 0.58 0.57 0.65
Short-Term Investments		 0.00 6.83 2.37 2.91 3.07
Accounts Receivable		 0.02 0.00 0.01 0.01 0.08
Inventories, net		 0.03 0.15 0.16 0.17 0.13
Prepaid Expenses		 0.04 0.27 0.32 0.29 0.36
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.00 0.01 0.20 0.26 0.34
Intangible Assets		 - 0.00 0.11 0.26 0.34
Other Noncurrent Operating Assets		 0.00 0.01 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 0.75 7.43 3.63 4.22 4.64
Total Liabilities		 2.44 1.95 0.43 0.55 0.89
Total Current Liabilities		 2.36 1.95 0.43 0.55 0.89
Accounts Payable		 0.84 0.66 0.16 0.16 0.24
Accrued Expenses		 0.61 0.54 0.26 0.39 0.64
Total Noncurrent Liabilities		 0.07 0.00 0.00 0.00 0.00
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -1.68 5.48 3.21 3.68 3.75
Total Preferred & Common Equity		 -1.68 5.48 3.21 3.68 3.75
Total Common Equity		 -1.68 5.48 3.21 3.68 3.75
Common Stock		 69 78 80 88 97
Retained Earnings		 -71 -72 -77 -85 -93
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.04 -0.00 -0.00 0.00

Quarterly Balance Sheets for Nexalin Technology

This table presents Nexalin Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 4.43 2.83 1.56 5.26 2.90 6.56 5.13 3.69
Total Current Assets		 4.26 2.56 1.18 4.91 2.62 6.27 4.82 3.29
Cash & Equivalents		 0.36 0.55 0.85 0.08 0.62 0.43 0.59 1.21
Short-Term Investments		 3.58 1.60 0.00 4.51 1.43 5.36 3.76 1.50
Accounts Receivable		 0.01 0.00 0.01 0.02 0.01 0.06 0.01 0.04
Inventories, net		 0.16 0.15 0.15 0.16 0.18 0.17 0.16 0.18
Prepaid Expenses		 0.15 0.26 0.18 0.14 0.38 0.24 0.30 0.36
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.17 0.27 0.38 0.35 0.28 0.29 0.31 0.40
Intangible Assets		 0.07 0.17 0.23 0.25 0.28 0.29 0.31 0.36
Other Noncurrent Operating Assets		 0.00 0.00 0.05 0.00 - 0.00 0.00 0.05
Total Liabilities & Shareholders' Equity		 4.43 2.83 1.56 5.26 2.90 6.56 5.13 3.69
Total Liabilities		 1.20 0.51 0.21 0.30 0.57 0.60 0.36 0.81
Total Current Liabilities		 1.20 0.51 0.21 0.30 0.57 0.60 0.36 0.81
Accounts Payable		 0.07 0.15 0.09 0.17 0.18 0.24 0.07 0.17
Accrued Expenses		 0.61 0.36 0.12 0.13 0.39 0.36 0.29 0.64
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 3.24 2.33 1.35 4.96 2.33 5.96 4.77 2.89
Total Preferred & Common Equity		 3.24 2.33 1.35 4.96 2.33 5.96 4.77 2.89
Total Common Equity		 3.24 2.33 1.35 4.96 2.33 5.96 4.77 2.89
Common Stock		 79 80 81 87 89 94 95 98
Retained Earnings		 -76 -78 -79 -82 -87 -88 -90 -95
Accumulated Other Comprehensive Income / (Loss)		 0.00 -0.00 0.00 -0.00 0.00 0.00 -0.00 0.00

Annual Metrics And Ratios for Nexalin Technology

This table displays calculated financial ratios and metrics derived from Nexalin Technology's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 7,279,961.00 7,436,562.00 12,861,605.00 18,651,939.00
DEI Adjusted Shares Outstanding		 0.00 7,279,961.00 7,436,562.00 12,861,605.00 18,651,939.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -0.23 -0.63 -0.59 -0.44
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 817.20% -91.62% 52.35% 78.78%
EBITDA Growth		 0.00% 73.01% -235.64% -41.77% -7.82%
EBIT Growth		 0.00% 73.00% -235.79% -41.94% -7.89%
NOPAT Growth		 0.00% 69.54% -210.76% -36.13% -8.20%
Net Income Growth		 0.00% 72.07% -173.81% -63.64% -8.08%
EPS Growth		 0.00% 79.02% -110.00% -31.75% 39.76%
Operating Cash Flow Growth		 0.00% -105.77% -73.10% -2.84% -25.69%
Free Cash Flow Firm Growth		 0.00% 0.00% -151.76% -5.76% -4.40%
Invested Capital Growth		 0.00% 43.08% 115.98% 20.91% -87.37%
Revenue Q/Q Growth		 0.00% 0.00% -13.91% 4.10% 92.22%
EBITDA Q/Q Growth		 0.00% 0.00% -15.86% -22.93% 5.34%
EBIT Q/Q Growth		 0.00% 0.00% -15.88% -22.93% 5.31%
NOPAT Q/Q Growth		 0.00% 0.00% -18.88% -19.23% 5.22%
Net Income Q/Q Growth		 0.00% 0.00% -1.62% -36.95% 5.26%
EPS Q/Q Growth		 0.00% 0.00% -1.61% -27.69% 25.37%
Operating Cash Flow Q/Q Growth		 0.00% -28.94% -2.61% -3.42% -0.27%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -6.84% 10.19%
Invested Capital Q/Q Growth		 0.00% 0.00% 154.70% -25.58% -94.04%
Profitability Metrics		 - - - - -
Gross Margin		 85.12% 72.51% 76.81% 78.31% 79.65%
EBITDA Margin		 -4,177.33% -122.94% -4,923.34% -4,581.66% -2,763.09%
Operating Margin		 -4,177.70% -138.72% -5,143.48% -4,596.14% -2,781.69%
EBIT Margin		 -4,177.70% -122.98% -4,927.18% -4,590.62% -2,770.23%
Profit (Net Income) Margin		 -4,218.93% -128.49% -4,197.56% -4,508.73% -2,725.76%
Tax Burden Percent		 99.62% 100.80% 100.00% 99.94% 100.01%
Interest Burden Percent		 101.37% 103.65% 85.19% 98.28% 98.38%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -3,029.86% -5,318.16%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -2,963.07% -5,252.95%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 2,808.81% 5,096.66%
Return on Equity (ROE)		 361.37% -89.44% -107.05% -221.05% -221.50%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -3,184.21% -3,048.79% -5,163.02%
Operating Return on Assets (OROA)		 -798.54% -39.70% -98.64% -197.22% -188.67%
Return on Assets (ROA)		 -806.42% -41.48% -84.03% -193.70% -185.64%
Return on Common Equity (ROCE)		 361.37% -89.44% -107.05% -221.05% -221.50%
Return on Equity Simple (ROE_SIMPLE)		 361.37% -30.99% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -4.21 -1.28 -3.99 -5.43 -5.87
NOPAT Margin		 -2,924.39% -97.11% -3,600.43% -3,217.29% -1,947.18%
Net Nonoperating Expense Percent (NNEP)		 -1,834.49% -12.57% -13.87% -66.79% -65.21%
Return On Investment Capital (ROIC_SIMPLE)		 - - -124.35% -147.67% -156.71%
Cost of Revenue to Revenue		 14.88% 80.02% 23.20% 21.69% 20.35%
SG&A Expenses to Revenue		 4,262.81% 158.71% 3,484.98% 3,968.62% 2,502.14%
R&D to Revenue		 0.00% 0.00% 1,735.30% 705.83% 359.20%
Operating Expenses to Revenue		 4,262.81% 158.71% 5,220.28% 4,674.45% 2,861.34%
Earnings before Interest and Taxes (EBIT)		 -6.02 -1.63 -5.46 -7.75 -8.36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.02 -1.62 -5.45 -7.73 -8.33
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 1.00 0.94 9.66 2.78
Price to Tangible Book Value (P/TBV)		 0.00 1.00 0.97 10.39 3.05
Price to Revenue (P/Rev)		 66.69 4.13 27.18 210.39 34.50
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 163.26 269.82
Enterprise Value to Revenue (EV/Rev)		 65.98 0.00 0.00 189.77 22.16
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 -0.33 0.09 0.00 0.00 0.00
Long-Term Debt to Equity		 -0.01 0.00 0.00 0.00 0.00
Financial Leverage		 0.06 -1.74 -1.10 -0.95 -0.97
Leverage Ratio		 -0.45 2.16 1.27 1.14 1.19
Compound Leverage Factor		 -0.45 2.23 1.09 1.12 1.17
Debt to Total Capital		 -49.93% 8.36% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 -47.89% 8.36% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 -2.04% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 149.93% 91.64% 100.00% 100.00% 100.00%
Debt to EBITDA		 -0.09 -0.31 0.00 0.00 0.00
Net Debt to EBITDA		 0.02 4.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.13 -0.39 0.00 0.00 0.00
Net Debt to NOPAT		 0.02 5.06 0.00 0.00 0.00
Long-Term Debt to NOPAT		 -0.01 0.00 0.00 0.00 0.00
Altman Z-Score		 -157.67 -11.62 -29.38 5.85 -26.01
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 0.32 3.81 8.07 7.25 4.85
Quick Ratio		 0.29 3.59 6.95 6.39 4.29
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -2.05 -5.16 -5.46 -5.70
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 -34.55 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -13.08 -37.31 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -13.08 -37.31 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.19 0.32 0.02 0.04 0.07
Accounts Receivable Turnover		 8.84 124.79 15.55 15.06 6.38
Inventory Turnover		 0.68 11.38 0.17 0.22 0.40
Fixed Asset Turnover		 138.66 1,713.82 0.00 0.00 0.00
Accounts Payable Turnover		 0.03 1.41 0.06 0.23 0.31
Days Sales Outstanding (DSO)		 41.30 2.93 23.47 24.24 57.24
Days Inventory Outstanding (DIO)		 534.68 32.07 2,208.00 1,650.78 910.08
Days Payable Outstanding (DPO)		 14,363.62 259.28 5,810.77 1,573.41 1,191.02
Cash Conversion Cycle (CCC)		 -13,787.64 -224.29 -3,579.29 101.62 -223.70
Capital & Investment Metrics		 - - - - -
Invested Capital		 -1.78 -1.02 0.16 0.20 0.02
Invested Capital Turnover		 -0.08 -0.94 -0.26 0.94 2.73
Increase / (Decrease) in Invested Capital		 0.00 0.77 1.18 0.03 -0.17
Enterprise Value (EV)		 9.51 -1.04 -0.03 32 6.68
Market Capitalization		 9.61 5.45 3.01 35 10
Book Value per Share		 ($0.40) $0.75 $0.43 $0.29 $0.20
Tangible Book Value per Share		 ($0.40) $0.75 $0.42 $0.27 $0.18
Total Capital		 -1.12 5.98 3.21 3.68 3.75
Total Debt		 0.56 0.50 0.00 0.00 0.00
Total Long-Term Debt		 0.02 0.00 0.00 0.00 0.00
Net Debt		 -0.10 -6.49 -3.04 -3.48 -3.72
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.74 -1.02 0.06 -0.07 -0.31
Debt-free Net Working Capital (DFNWC)		 -1.07 5.98 3.00 3.41 3.41
Net Working Capital (NWC)		 -1.61 5.48 3.00 3.41 3.41
Net Nonoperating Expense (NNE)		 1.86 0.41 0.66 2.18 2.35
Net Nonoperating Obligations (NNO)		 -0.10 -6.49 -3.04 -3.48 -3.72
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.02 0.02
Debt-free, Cash-free Net Working Capital to Revenue		 -1,204.70% -77.00% 50.73% -38.81% -103.19%
Debt-free Net Working Capital to Revenue		 -745.34% 452.30% 2,713.02% 2,023.72% 1,131.10%
Net Working Capital to Revenue		 -1,118.23% 414.46% 2,713.02% 2,023.72% 1,131.10%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.30) ($0.63) $0.00 ($0.50)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 7.29M 7.36M 0.00 16.39M
Adjusted Diluted Earnings per Share		 $0.00 ($0.30) ($0.63) $0.00 ($0.50)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 7.29M 7.36M 0.00 16.39M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($0.30) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 5.57M 7.44M 0.00 20.58M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.21 -1.28 -3.99 -5.43 -5.87
Normalized NOPAT Margin		 -2,924.39% -97.11% -3,600.43% -3,217.29% -1,947.18%
Pre Tax Income Margin		 -4,234.84% -127.48% -4,197.56% -4,511.61% -2,725.42%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 -73.11 -27.37 0.00 0.00 0.00
NOPAT to Interest Expense		 -51.18 -21.61 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -73.11 -27.37 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -51.18 -21.61 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Nexalin Technology

This table displays calculated financial ratios and metrics derived from Nexalin Technology's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 7,436,562.00 7,436,562.00 7,436,562.00 7,436,562.00 10,586,562.00 12,861,605.00 13,303,523.00 17,177,929.00 17,647,130.00 18,651,939.00 20,581,646.00
DEI Adjusted Shares Outstanding		 7,436,562.00 7,436,562.00 7,436,562.00 7,436,562.00 10,586,562.00 12,861,605.00 13,303,523.00 17,177,929.00 17,647,130.00 18,651,939.00 20,581,646.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.31 -0.11 -0.14 -0.17 -0.23 -0.22 -0.15 -0.09 -0.13 -0.13 -0.10
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -95.58% -46.56% 157.43% -24.48% 49.43% 32.35% -47.87% 163.00% -49.63% 532.46% -63.55%
EBITDA Growth		 -1,801.96% -109.80% -37.55% -47.57% -5.37% -101.12% -87.35% -24.92% 7.26% 16.38% -5.16%
EBIT Growth		 -1,800.62% -110.01% -37.75% -47.86% -5.51% -101.18% -87.33% -24.95% 7.20% 16.30% -5.45%
NOPAT Growth		 -723.87% -125.74% -37.76% -47.92% -3.85% -77.00% -87.32% -24.97% 6.49% 16.08% -5.40%
Net Income Growth		 -1,596.58% -10.46% -39.12% -56.18% -6.58% -262.93% -90.97% -23.08% 7.02% 16.12% -5.46%
EPS Growth		 -933.33% -10.00% -40.00% -54.55% 25.81% -163.64% -7.14% 41.18% 43.48% 58.62% 26.67%
Operating Cash Flow Growth		 25.71% -10.76% 41.94% -52.82% -14.14% -12.99% -86.85% 26.42% -83.23% -1.19% -20.11%
Free Cash Flow Firm Growth		 -398.94% 0.00% -247.54% -268.95% 3.65% 11.57% -49.55% 40.30% 22.53% 25.84% 13.33%
Invested Capital Growth		 70.62% 115.98% 134.20% 297.27% 188.88% 20.91% 237.55% -57.53% 57.76% -87.37% -35.19%
Revenue Q/Q Growth		 -32.15% -14.84% 283.11% -65.88% 34.24% -24.57% 50.91% 72.10% -74.29% 847.13% -91.30%
EBITDA Q/Q Growth		 -171.31% 39.93% 25.00% -20.73% -93.73% -14.66% 30.14% 19.50% -43.83% -3.37% 12.14%
EBIT Q/Q Growth		 -171.16% 39.88% 24.91% -20.78% -93.49% -14.64% 30.08% 19.44% -43.71% -3.39% 11.91%
NOPAT Q/Q Growth		 -175.48% 32.75% 33.90% -20.80% -93.41% -14.63% 30.05% 19.41% -44.72% -2.88% 12.15%
Net Income Q/Q Growth		 -179.31% 66.02% -33.37% -23.37% -90.60% -15.73% 29.82% 20.49% -43.98% -4.40% 11.77%
EPS Q/Q Growth		 -181.82% 64.52% -27.27% -21.43% -35.29% -26.09% 48.28% 33.33% -30.00% 7.69% 8.33%
Operating Cash Flow Q/Q Growth		 14.04% -43.21% 23.98% -63.30% 35.80% -41.77% -25.72% 35.69% -59.87% 21.70% -49.21%
Free Cash Flow Firm Q/Q Growth		 -486.04% 3.71% 53.75% -41.37% -53.04% 11.63% 21.78% 43.56% -98.58% 15.40% 8.59%
Invested Capital Q/Q Growth		 -45.60% 154.70% -49.90% 394.37% -34.40% -25.58% 39.86% -37.80% 143.67% -94.04% 617.62%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 83.52% 74.53% 88.36% 73.00% 64.77% 72.42% 66.94% 67.65% 78.25% 87.77% 87.85%
EBITDA Margin		 -9,844.96% -6,944.53% -1,359.49% -4,810.71% -6,942.51% -10,552.46% -4,885.35% -2,285.08% -12,782.52% -1,395.13% -14,094.00%
Operating Margin		 -10,017.57% -7,910.75% -1,364.81% -4,832.42% -6,962.11% -10,579.48% -4,903.63% -2,296.22% -12,924.30% -1,403.86% -14,179.95%
EBIT Margin		 -9,848.64% -6,953.04% -1,362.88% -4,824.84% -6,954.20% -10,568.80% -4,897.02% -2,292.34% -12,812.68% -1,398.71% -14,166.53%
Profit (Net Income) Margin		 -9,526.77% -3,801.65% -1,323.43% -4,785.74% -6,794.86% -10,424.50% -4,847.83% -2,239.74% -12,542.35% -1,382.56% -14,025.67%
Tax Burden Percent		 100.00% 100.00% 99.45% 100.10% 99.99% 99.99% 100.05% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 96.73% 54.68% 97.65% 99.09% 97.72% 98.64% 98.94% 97.71% 97.89% 98.85% 99.01%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -5,128.39% 0.00% -6,974.19% -2,530.59% -981.88% -4,180.28% -2,683.97% -12,101.47%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -5,113.76% 0.00% -6,949.04% -2,503.57% -968.63% -4,166.26% -2,664.88% -12,075.72%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 4,924.20% 0.00% 6,587.27% 2,312.24% 892.84% 3,875.30% 2,585.59% 11,028.22%
Return on Equity (ROE)		 -95.39% -107.05% -139.94% -204.19% -135.57% -386.92% -218.36% -89.04% -304.99% -98.37% -1,073.25%
Cash Return on Invested Capital (CROIC)		 0.00% -3,184.21% -5,552.73% -1,267.73% -1,940.10% -3,048.79% -3,531.10% -2,124.61% -1,869.49% -5,163.02% -2,589.44%
Operating Return on Assets (OROA)		 -198.16% -139.20% -49.40% -215.02% -232.61% -454.04% -223.85% -98.62% -387.30% -95.26% -1,183.99%
Return on Assets (ROA)		 -191.69% -76.11% -47.97% -213.28% -227.28% -447.84% -221.61% -96.35% -379.13% -94.16% -1,172.21%
Return on Common Equity (ROCE)		 -95.39% -107.05% -139.94% -204.19% -135.57% -386.92% -218.36% -89.04% -304.99% -98.37% -1,073.25%
Return on Equity Simple (ROE_SIMPLE)		 -141.34% 0.00% -212.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.69 -1.14 -0.75 -0.91 -1.76 -2.01 -1.41 -1.13 -1.64 -1.69 -1.48
NOPAT Margin		 -7,012.30% -5,537.53% -955.37% -3,382.69% -4,873.48% -7,405.63% -3,432.54% -1,607.36% -9,047.01% -982.70% -9,925.96%
Net Nonoperating Expense Percent (NNEP)		 -11.13% 7.47% -8.02% -14.64% -16.83% -25.15% -27.02% -13.24% -14.02% -19.08% -25.75%
Return On Investment Capital (ROIC_SIMPLE)		 - -35.46% -32.30% -67.20% -35.42% -54.75% -60.54% -19.03% -34.43% -45.07% -51.41%
Cost of Revenue to Revenue		 16.48% 25.47% 11.64% 27.00% 35.23% 27.58% 33.06% 32.35% 21.75% 12.23% 12.15%
SG&A Expenses to Revenue		 10,101.09% -1,373.43% 1,318.86% 4,274.23% 6,531.29% 7,939.36% 3,979.99% 2,044.02% 11,754.43% 1,360.77% 11,950.86%
R&D to Revenue		 0.00% 0.00% 134.32% 631.18% 495.59% 2,712.54% 990.58% 319.85% 1,248.11% 130.86% 2,316.94%
Operating Expenses to Revenue		 10,101.09% 7,985.28% 1,453.17% 4,905.42% 7,026.88% 10,651.90% 4,970.58% 2,363.87% 13,002.55% 1,491.63% 14,267.79%
Earnings before Interest and Taxes (EBIT)		 -2.37 -1.43 -1.07 -1.29 -2.51 -2.87 -2.01 -1.62 -2.33 -2.40 -2.12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.37 -1.43 -1.07 -1.29 -2.50 -2.87 -2.00 -1.61 -2.32 -2.40 -2.11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.01 0.94 4.47 9.30 1.43 9.66 11.16 2.85 3.39 2.78 2.48
Price to Tangible Book Value (P/TBV)		 1.03 0.97 4.82 11.17 1.50 10.39 12.68 2.99 3.63 3.05 2.84
Price to Revenue (P/Rev)		 25.43 27.18 65.54 83.70 43.69 210.39 197.93 97.07 103.14 34.50 26.01
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 100.48 28.92 9.06 163.26 87.10 65.50 28.46 269.82 25.09
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 51.40 77.37 14.73 189.77 182.28 63.93 75.40 22.16 16.18
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.14 -1.10 -1.02 -0.96 -1.00 -0.95 -0.92 -0.92 -0.93 -0.97 -0.91
Leverage Ratio		 1.33 1.27 1.24 1.26 1.18 1.14 1.23 1.11 1.07 1.19 1.27
Compound Leverage Factor		 1.29 0.70 1.21 1.25 1.16 1.13 1.22 1.09 1.05 1.18 1.25
Debt to Total Capital		 13.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 13.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 86.62% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 -0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 1.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -23.35 -25.72 -26.57 -37.42 -8.09 9.66 -16.13 -1.61 2.03 -21.77 -31.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.56 8.07 5.05 5.57 16.39 7.25 4.56 10.44 13.47 4.85 4.07
Quick Ratio		 3.30 6.95 4.23 4.06 15.39 6.39 3.59 9.74 12.20 4.29 3.40
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.40 -2.31 -1.07 -1.51 -2.32 -2.05 -1.60 -0.90 -1.79 -1.52 -1.39
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -3,476.31%
Free Cash Flow to Firm to Interest Expense		 -450.97 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -131.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -131.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.02 0.02 0.04 0.04 0.03 0.04 0.05 0.04 0.03 0.07 0.08
Accounts Receivable Turnover		 10.36 15.55 44.03 11.53 10.93 15.06 14.45 4.89 13.59 6.38 9.59
Inventory Turnover		 4.64 0.17 0.18 0.17 0.22 0.22 0.25 0.36 0.30 0.40 0.28
Fixed Asset Turnover		 349.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 1.68 0.06 0.27 0.38 0.29 0.23 0.25 0.35 0.41 0.31 0.28
Days Sales Outstanding (DSO)		 35.23 23.47 8.29 31.65 33.39 24.24 25.27 74.71 26.86 57.24 38.07
Days Inventory Outstanding (DIO)		 78.60 2,208.00 2,052.67 2,174.78 1,685.25 1,650.78 1,464.28 1,025.98 1,215.40 910.08 1,304.41
Days Payable Outstanding (DPO)		 217.77 5,810.77 1,357.32 966.69 1,271.09 1,573.41 1,482.01 1,056.95 892.80 1,191.02 1,285.11
Cash Conversion Cycle (CCC)		 -103.94 -3,579.29 703.64 1,239.73 447.55 101.62 7.53 43.74 349.46 -223.70 57.37
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.30 0.16 0.08 0.40 0.26 0.20 0.27 0.17 0.42 0.02 0.18
Invested Capital Turnover		 -0.20 -0.26 -2.03 1.52 -9.83 0.94 0.74 0.61 0.46 2.73 1.22
Increase / (Decrease) in Invested Capital		 0.71 1.18 0.32 0.61 0.56 0.03 0.19 -0.23 0.15 -0.17 -0.10
Enterprise Value (EV)		 -0.26 -0.03 8.17 12 2.39 32 24 11 12 6.68 4.46
Market Capitalization		 3.27 3.01 10 13 7.08 35 26 17 16 10 7.17
Book Value per Share		 $0.44 $0.43 $0.31 $0.18 $0.47 $0.29 $0.17 $0.35 $0.27 $0.20 $0.14
Tangible Book Value per Share		 $0.43 $0.42 $0.29 $0.15 $0.44 $0.27 $0.15 $0.33 $0.25 $0.18 $0.12
Total Capital		 3.74 3.21 2.33 1.35 4.96 3.68 2.33 5.96 4.77 3.75 2.89
Total Debt		 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -3.53 -3.04 -2.25 -0.95 -4.69 -3.48 -2.05 -5.79 -4.35 -3.72 -2.71
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.37 0.06 -0.09 0.12 0.01 -0.07 -0.01 -0.12 0.11 -0.31 -0.23
Debt-free Net Working Capital (DFNWC)		 3.57 3.00 2.06 0.97 4.61 3.41 2.05 5.67 4.46 3.41 2.48
Net Working Capital (NWC)		 3.07 3.00 2.06 0.97 4.61 3.41 2.05 5.67 4.46 3.41 2.48
Net Nonoperating Expense (NNE)		 0.61 -0.36 0.29 0.38 0.69 0.82 0.58 0.45 0.63 0.69 0.61
Net Nonoperating Obligations (NNO)		 -3.53 -3.04 -2.25 -0.95 -4.69 -3.48 -2.05 -5.79 -4.35 -3.72 -2.71
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Debt-free, Cash-free Net Working Capital to Revenue		 -288.35% 50.73% -55.34% 80.74% 9.00% -38.81% -3.99% -71.08% 68.30% -103.19% -82.26%
Debt-free Net Working Capital to Revenue		 2,772.35% 2,713.02% 1,294.25% 646.01% 2,843.22% 2,023.72% 1,560.95% 3,242.62% 2,841.92% 1,131.10% 900.56%
Net Working Capital to Revenue		 2,383.66% 2,713.02% 1,294.25% 646.01% 2,843.22% 2,023.72% 1,560.95% 3,242.62% 2,841.92% 1,131.10% 900.56%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.31) ($0.11) ($0.14) ($0.17) ($0.23) ($0.29) ($0.15) ($0.10) ($0.13) ($0.12) ($0.11)
Adjusted Weighted Average Basic Shares Outstanding		 7.42M 7.36M 7.44M 7.50M 10.85M 9.22M 13.31M 15.72M 17.79M 16.39M 19.82M
Adjusted Diluted Earnings per Share		 ($0.31) ($0.11) ($0.14) ($0.17) ($0.23) ($0.29) ($0.15) ($0.10) ($0.13) ($0.12) ($0.11)
Adjusted Weighted Average Diluted Shares Outstanding		 7.42M 7.36M 7.44M 7.50M 10.85M 9.22M 13.31M 15.72M 17.79M 16.39M 19.82M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 7.44M 7.44M 7.44M 10.59M 12.86M 13.30M 17.18M 17.42M 18.65M 20.58M 20.58M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.69 -1.14 -0.75 -0.91 -1.76 -2.01 -1.41 -1.13 -1.64 -1.69 -1.48
Normalized NOPAT Margin		 -7,012.30% -5,537.53% -955.37% -3,382.69% -4,873.48% -7,405.63% -3,432.54% -1,607.36% -9,047.01% -982.70% -9,925.96%
Pre Tax Income Margin		 -9,526.77% -3,801.65% -1,330.78% -4,780.93% -6,795.30% -10,425.24% -4,845.27% -2,239.74% -12,542.35% -1,382.56% -14,025.67%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -445.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -317.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -445.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -317.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Nexalin Technology (NASDAQ: NXL) shows a mixed but clearly still pre-profitability financial profile. Revenue remains very small and quarterly losses continue, but the company ended Q1 2026 with a much stronger balance sheet than it had a year earlier, largely because of its investment portfolio and financing activity. At the same time, operating losses remain sizable relative to revenue, and share count has risen meaningfully over the past year.

  • Liquidity improved materially. Nexalin ended Q1 2026 with $1.2 million in cash, $1.5 million in short-term investments, and $3.3 million in current assets versus $2.9 million in total assets a year earlier in Q1 2024. That suggests a much larger liquidity base than it had in early 2024.
  • Equity increased sharply year over year. Total common equity was $2.9 million in Q1 2026, up from $2.3 million in Q1 2025 and well above the $2.3 million in Q1 2024.
  • Operating cash burn improved versus last quarter. Net cash used in operating activities was $(1.71) million in Q1 2026, better than $(2.38) million in Q4 2025 and also better than $(1.48) million in Q3 2025.
  • Cash generation from investing activity helped offset operations. In Q1 2026, Nexalin generated $1.51 million from investing activities, supported by sales/maturity of investments.
  • The company continued to hold a sizable investment portfolio relative to its size. Short-term investments were the largest liquid asset on the Q1 2026 balance sheet at $1.5 million.
  • Revenue remains extremely small. Q1 2026 revenue was just $14,950, down from $171,895 in Q4 2025 and well below the quarterly swings seen in 2024 and 2025. This makes results highly volatile.
  • Gross margin looks positive, but the dollar amount is tiny. Q1 2026 gross profit was only $13,133, which is not enough to meaningfully offset overhead.
  • Interest and other income are helping results at the margin. Q1 2026 had $21,025 of interest and investment income and $2,006 of other income, but these items are small compared with operating losses.
  • Share count has increased over time. Weighted average basic shares rose to 19.8 million in Q1 2026 from 13.3 million in Q1 2025 and 7.4 million in Q1 2024, indicating meaningful dilution over the last year.
  • Operating losses remain large. Nexalin reported an operating loss of $(2.12) million in Q1 2026, only slightly better than the $(2.41) million loss in Q4 2025 and still far larger than revenue.
  • Net loss remains substantial. Q1 2026 net loss was $(2.10) million, compared with $(2.38) million in Q4 2025 and $(2.28) million in Q3 2025.
  • SG&A expense is still the biggest cost burden. Q1 2026 SG&A was $1.79 million, which dwarfed revenue and consumed most of the gross profit.
  • Retained earnings remain deeply negative. Q1 2026 retained earnings were $(94.96) million, reflecting a long history of losses.
  • Heavy dependence on financing remains a risk. Q1 2026 cash from financing was $756,421, and the company has repeatedly relied on external funding and/or investment liquidation to support operations.

Bottom line: Nexalin’s near-term liquidity appears better than in prior periods, but the business still has not shown a sustained path to meaningful revenue growth or operating leverage. For retail investors, the key issue is whether the company can scale sales before ongoing losses and dilution become more damaging.

07/20/26 08:56 AM ETAI Generated. May Contain Errors.

Nexalin Technology Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nexalin Technology's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Nexalin Technology's net income appears to be on an upward trend, with a most recent value of -$8.22 million in 2025, rising from -$6.08 million in 2021. The previous period was -$7.61 million in 2024. See Nexalin Technology's forecast for analyst expectations on what's next for the company.

Nexalin Technology's total operating income in 2025 was -$8.39 million, based on the following breakdown:
  • Total Gross Profit: $240.27 thousand
  • Total Operating Expenses: $8.63 million

Over the last 4 years, Nexalin Technology's total revenue changed from $144.07 thousand in 2021 to $301.65 thousand in 2025, a change of 109.4%.

Nexalin Technology's total liabilities were at $887.33 thousand at the end of 2025, a 62.3% increase from 2024, and a 63.6% decrease since 2021.

In the past 4 years, Nexalin Technology's cash and equivalents has ranged from $162.74 thousand in 2022 to $661.78 thousand in 2021, and is currently $654.78 thousand as of their latest financial filing in 2025.

Over the last 4 years, Nexalin Technology's book value per share changed from -0.40 in 2021 to 0.20 in 2025, a change of -150.8%.


Related Companies

Financial statements for NASDAQ:NXL last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
NVIDIA offered $40B. The answer was no.
Apple, NVIDIA, Google, Amazon, and Samsung all pay one company billions in royalties every year. NVIDIA tried ...
Behind the Markets | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
The gold strategy buried in Trump's plans that insiders are already watching
Nancy Pelosi's portfolio gained 71 percent in 2024 while the S&P 500 returned just 28 percent. In 2023, she ea...
American Alternative | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
This same-day trade is getting a lot of attention
Zero-days-to-expiration trades happen every single day - and most traders either ignore them or use them wrong...
Base Camp Trading | Sponsoredtc pixel
The chipmaker 148 times smaller than NVIDIA supplying Musk
According to Yahoo Finance, Elon Musk's latest project could 'upend another industry just as he did with cars ...
Brownstone Research | Sponsoredtc pixel
Gold Is About to Do Something It Hasn’t in 90 Years
The U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...
US Gold Bureau | Sponsoredtc pixel